The electronic lab notebook leverages AI to accelerate biopharma research and development
AI laboratory informatics specialist Sapio Sciences has launched the third generation of its Electronic Lab Notebook (ELN), Sapio ELaiN.
“Instead of merely recording and storing data, Sapio ELaiN acts as a new kind of agentic AI scientific collaborator, guiding scientists at every step,” said Sapio Sciences CEO and CTO Kevin Cramer. “It understands context, helps plan and design experiments, and analyses results, always ensuring work is documented, repeatable, and compliant.
Sapio ELaiN accelerates biopharma research and development by leveraging agentic and generative AI that helps to plan, design and analyse experiments.
Traditional ELNs have been limited to recording and documenting research, with some more recent ELNs also modelling and analysing data. The rigidity of these traditional ELNs resulted in most of the research burden remaining on scientists.
ELaiN, however, is able to support scientists with tasks such as accessing and searching data, designing and building experiments from existing protocols and analysing results with embedded scientific methods. This ultimately helps to accelerate therapeutic pipelines and decision-making.
Ai-powered capabilities of the ELaiN include:
-
Molecular docking simulation: Performance of binding simulations between compounds and targets to accelerate lead identification and optimisation.
-
Ad hoc data analytics: Analysation and visualisation of complex data tables to uncover trends, patterns, and insights.
-
Codon optimisation: Automatic optimisation of genetic sequences for expression across different systems.
-
Small molecule analysis: Planning of retrosynthesis routes, prediction of toxicity and solubility, and assessment of buyability with AI-powered chemistry tools integrated directly into the notebook.
-
Protocol-based experimentation: Build and execution of experiments directly from protocol descriptions in text form, with AI assistance.
-
Expanding capabilities: A continuous development pipeline ensures new scientific functions are added regularly.
The AI-native platform is scientifically fluent across research and development areas such as cheminformatics, bioinformatics, and structure-based design.
Earlier this month, Sapio Sciences partnered its AI-powered laboratory informatics solutions with biotechnology company Ultima’s sequencing platform to make multi-omics workflows more accessible and streamlined for researchers.
